Q3 2024 Holdings
Filed 2024-11-14 | 11 holdings | $269.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $141.1M | 12,228,465 | 52.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $71.8M | 7,182,532 | 26.7% |
| Cullinan Therapeutics, Inc.(CGEM) | COM | 230031106 | $13.8M | 824,705 | 5.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $12.5M | 171,704 | 4.7% |
| Eyepoint Pharmaceuticals(EYPT) | COM NEW | 30233G209 | $10.9M | 1,361,979 | 4.0% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $7.3M | 325,789 | 2.7% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $4.5M | 242,341 | 1.7% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $2.6M | 128,569 | 1.0% |
| Enliven Therapeutics, Inc.(ELVN) | COM | 29337E102 | $2.3M | 90,572 | 0.9% |
| Ocular Therapeutix, Inc.(OCUL) | COM | 67576A100 | $2.0M | 235,498 | 0.8% |
| Astria Therapeutics, Inc.(CATBUSD) | COM | 04635X102 | $434.0K | 39,422 | 0.2% |